ライフサイエンスコーパス: peripheral blood mononuclear cell

1 vo than either GG or AG (p < 0.001) in total peripheral blood mononuclear cells.

2 ase-1, and mature interleukin-1beta in human peripheral blood mononuclear cells.

3 d immortalized cells such as HEK293 or human peripheral blood mononuclear cells.

4 s, human colonic epithelial cells, and human peripheral blood mononuclear cells.

5 ns reduces human antibody binding to porcine peripheral blood mononuclear cells.

6 d induction of TNF-alpha production by human peripheral blood mononuclear cells.

7 stence of proviruses of HIV-1 in circulating peripheral blood mononuclear cells.

8 ls, and are able to suppress activated human peripheral blood mononuclear cells.

9 phatase-1 were determined in neutrophils and peripheral blood mononuclear cells.

10 issue (AT) as well as in subcutaneous AT and peripheral blood mononuclear cells.

11 tic mutations in KRAS or NRAS genes noted in peripheral blood mononuclear cells.

12 ty was confirmed on TLR7/8 activity in human peripheral blood mononuclear cells.

13 ther with global gene-expression analyses in peripheral blood mononuclear cells.

14 fected human lymphoid aggregate cultures and peripheral blood mononuclear cells.

15 and Kruppel-like factor 2) protein levels in peripheral blood mononuclear cells.

16 when tested against HIV-1Ba-L replication in peripheral blood mononuclear cells.

17 ditional postentry blocks in common marmoset peripheral blood mononuclear cells.

18 mmadelta T-cell clones could be derived from peripheral blood mononuclear cells.

19 n human cell lines, primary macrophages, and peripheral blood mononuclear cells.

20 ce the activation of in vitro-cultured human peripheral blood mononuclear cells.

21 and acutely HIV-1 infected T cells by human peripheral blood mononuclear cells.

22 ses were studied in 42 vaccinees using fresh peripheral blood mononuclear cells.

23 ntiation of CD4+ T cells isolated from human peripheral blood mononuclear cells.

24 ricted peptide from a viral antigen in human peripheral blood mononuclear cells.

25 d D-dimer levels were associated with higher peripheral blood mononuclear cell and gut integrated HIV

26 unoCloak treatment was evaluated using human peripheral blood mononuclear cells and by testing for an

27 tect HLA-DR-presented peptides in synovia or peripheral blood mononuclear cells and identified 2 auto

28 , induced proinflammatory responses in human peripheral blood mononuclear cells and in monocolonized

29 In an analysis of peripheral blood mononuclear cells and intestinal tissue

30 We collected samples of peripheral blood mononuclear cells and intestinal tissue

31 ere mainly of a memory phenotype, present in peripheral blood mononuclear cells and intestinal tissue

32 type and nectin-4-blind MeV were detected in peripheral blood mononuclear cells and lymph node homoge

33 Patient's and father's peripheral blood mononuclear cells and macrophages demon

34 e the expression of CD300 receptors on adult peripheral blood mononuclear cells and neonatal cord blo

35 Vdelta2(neg) gammadelta T-cell subset within peripheral blood mononuclear cells and other annexin A2-

36 By sorting human peripheral blood mononuclear cells and performing quanti

37 performed multi-platform 'omics analysis of peripheral blood mononuclear cells and plasma from EVD p

38 showed enhanced histone (H3) acetylation in peripheral blood mononuclear cells and reduced interleuk

39 Peripheral blood mononuclear cells and sera were obtaine

40 Cryopreserved peripheral blood mononuclear cells and serum samples col

41 Peripheral blood mononuclear cells and serum were separa

42 thermore, increases in SMN protein levels in peripheral blood mononuclear cells and skin correlate wi

43 3G, and assays testing antiviral activity in peripheral blood mononuclear cells and T cells were empl

44 DACs and reduces caspase-1 activity in human peripheral blood mononuclear cells and the secretion of

45 al and noncanonical pathways was examined in peripheral blood mononuclear cells and transfected HEK29

46 wide range of cancers, does not bind normal peripheral blood mononuclear cells, and can activate imm

47 s by reprogramming microglia-like cells from peripheral blood mononuclear cells, and combining them w

48 per muL, median HIV DNA 170 copies per 10(6) peripheral blood mononuclear cells, and duration of anti

49 o against Daudi cells with cynomolgus monkey peripheral blood mononuclear cells, and had minimal comp

50 t, quantification of HTLV-1 proviral load in peripheral blood mononuclear cells, and human leukocyte

51 cyte-derived dendritic cells [moDCs], PBMCs [peripheral blood mononuclear cells] and epithelial and i

52 -I-transformed and ATL cells, but not normal peripheral blood mononuclear cells, are highly sensitive

53 ytometry in a mimetic cell mixture and human peripheral blood mononuclear cells as model systems.

54 microarray gene expression data derived from peripheral blood mononuclear cells as well as 16S riboso

55 Neutralizing antibodies were detected in a peripheral blood mononuclear cell assay, and moderate an

56 -induced cytokine responses) from stimulated peripheral blood mononuclear cells at age 3 years.

57 ug, exerts anti-HIV-1 activity in TZM-bl and peripheral blood mononuclear cells at low nanomolar conc

58 0.5 log10 or greater decrease in HIV DNA in peripheral blood mononuclear cells at week 56.

59 Multicolor flow cytometry of peripheral blood mononuclear cells before transplantatio

60 n brain regions (BP case/control: 45/50) and peripheral blood mononuclear cells (BP case/control: 193

61 This dose decreased DNMT1 protein in peripheral blood mononuclear cells by >75% and repetitiv

62 PCV13 serotypes 6A and 19A were measured in peripheral blood mononuclear cells by enzyme-linked immu

63 Compared with unselected peripheral blood mononuclear cells, CMV-CTLs induced sig

64 nd the immunosuppressive effect of hBMSC and peripheral blood mononuclear cell co-cultured exosomes f

65 Peripheral blood mononuclear cells collected during epis

66 The corticosteroid sensitivity of peripheral blood mononuclear cells collected from patien

67 Peripheral blood mononuclear cells, collected before (on

68 Mo-MDSCs were elevated in psoriatic patient peripheral blood mononuclear cells compared to nonpsoria

69 fold higher levels of IFN-gamma and IL-17 in peripheral blood mononuclear cells compared with healthy

70 n and activity of ADAM-10 and ADAM-17 in old peripheral blood mononuclear cells compared with those o

71 xpression of several IFN-stimulated genes in peripheral blood mononuclear cells, compared to pigs tre

72 1 infection induces LY6E expression in human peripheral blood mononuclear cells, concomitant with inc

73 roduction and the CD4(+) T-cell phenotype in peripheral blood mononuclear cell cultures.

74 stress/depression to recurrent wheezing and peripheral blood mononuclear cell cytokine responses at

75 Nonetheless, peripheral blood mononuclear cell DEGs associated with m

76 y, the expression analysis of U1 and patient peripheral blood mononuclear cells demonstrated a major

77 Peripheral blood mononuclear cell-derived DEGs were more

78 sequencing of MTAP/CDKN2A-CDKN2B loci in 77 peripheral blood mononuclear cell DNA samples from patie

79 of telomeres was measured longitudinally in peripheral blood mononuclear cells during human aging, i

80 OLM-4, THP-1 or primary AML cells with donor peripheral blood mononuclear cells elicited a cell conta

81 ing of HIV-1 DNA derived from unfractionated peripheral blood mononuclear cells, ex vivo-isolated CD4

82 een the levels of cellular IL-10 secreted in peripheral blood mononuclear cells exposed to RhCMV anti

83 hesis, the transcriptional profiles of total peripheral blood mononuclear cells following delivery in

84 DNA double-strand breaks were determined in peripheral blood mononuclear cells from 13 pSS patients,

85 roduction, we profiled cytokines produced by peripheral blood mononuclear cells from 197 individuals

86 , measured in blood and urine, and %PTHMs in peripheral blood mononuclear cells from 317 participants

87 we compared hsa-miRNA expression profiles in peripheral blood mononuclear cells from 35 transplant re

88 We isolated peripheral blood mononuclear cells from 65 patients with

89 Transcriptional profiling of peripheral blood mononuclear cells from AA or white, nor

90 Analysis of peripheral blood mononuclear cells from age-matched heal

91 Analysis of peripheral blood mononuclear cells from an affected subj

92 observed in 7% and 56% of tax sequences from peripheral blood mononuclear cells from animals 12141 an

93 Peripheral blood mononuclear cells from cases had shorte

94 ir immunogenic potential was evaluated using peripheral blood mononuclear cells from celiac patients

95 criptome microarray data were generated from peripheral blood mononuclear cells from Chinese children

96 Peripheral blood mononuclear cells from chronic lymphocy

97 ized to the responses previously observed in peripheral blood mononuclear cells from donors from regi

98 immunogenicity in A2-transgenic mice and on peripheral blood mononuclear cells from ESO-vaccinated m

99 Peripheral blood mononuclear cells from healthy controls

100 We stimulated peripheral blood mononuclear cells from healthy donors a

101 Peripheral blood mononuclear cells from healthy donors w

102 Peripheral blood mononuclear cells from healthy subjects

103 Peripheral blood mononuclear cells from healthy voluntee

104 inhibited IFN-gamma and IL-17A production in peripheral blood mononuclear cells from HIV-infected ART

105 Peripheral blood mononuclear cells from HIV-infected wom

106 YILIRD-reactive CD4(+)T cells are present in peripheral blood mononuclear cells from HLA-DRB1*11 and

107 Peripheral blood mononuclear cells from immune donors we

108 phages to contain M. tuberculosis We exposed peripheral blood mononuclear cells from M. tuberculosis-

109 Peripheral blood mononuclear cells from male children wi

110 sy samples and Leishmania antigen-stimulated peripheral blood mononuclear cells from patients infecte

111 We collected peripheral blood mononuclear cells from patients with AL

112 mTOR activity was increased in peripheral blood mononuclear cells from patients with CO

113 spective study, ex vivo phenotyping of fresh peripheral blood mononuclear cells from patients with pr

114 In peripheral blood mononuclear cells from patients with SS

115 Set7 expression increased in peripheral blood mononuclear cells from patients with T2

116 Peripheral blood mononuclear cells from SLA identical wi

117 Unexpectedly, pathogen-stimulated peripheral blood mononuclear cells from subjects homozyg

118 Peripheral blood mononuclear cells from these donors wer

119 B lymphoblastoid cell lines (BLCLs), but not peripheral blood mononuclear cells, from which they were

120 ents with proviral load >50,000 copies/10(6) peripheral blood mononuclear cells had a higher risk of

121 Acute respiratory distress syndrome peripheral blood mononuclear cells had a three-fold incr

122 rimates resulted in persistent NTP levels in peripheral blood mononuclear cells (half-life, 14 h) and

123 The production of interferon-gamma by peripheral blood mononuclear cells in the anakinra arm w

124 KLOTHO gene expression in peripheral blood mononuclear cells increased by 45.7% in

125 Conversely, addition of sialidases to human peripheral blood mononuclear cells induces accumulation

126 Human IgG, eluted from human and pig peripheral blood mononuclear cells, interacted across sp

127 ed HLA-DQ-gluten tetramers and added them to peripheral blood mononuclear cells isolated from 143 HLA

128 Peripheral blood mononuclear cells isolated from CHIKV-i

129 ve TLR7 agonist, GS-9620, activated HIV from peripheral blood mononuclear cells isolated from HIV-inf

130 ilar increases in SHP2 activity were seen in peripheral blood mononuclear cells isolated from lupus p

131 Transcriptional profiling of peripheral blood mononuclear cells isolated within the f

132 than intra-arterial infusion, and mobilized peripheral blood mononuclear cells may outperform bone m

133 In particular, exposure of macrophages, peripheral blood mononuclear cells, monocyte-derived den

134 kin injury caused by transferring allogeneic peripheral blood mononuclear cells more effectively than

135 dian magnitude: 397 spot-forming units/10(6) peripheral blood mononuclear cells), most frequently tar

136 ients) or unfractionated bone marrow (BM) or peripheral blood mononuclear cells (n = 10) resulted in

137 ctivation also occurred in liver samples and peripheral blood mononuclear cells of patients with ALD/

138 , and the constitutive IL-1beta release from peripheral blood mononuclear cells of patients with FMF

139 al activity of RXRalpha is down-modulated in peripheral blood mononuclear cells of patients with lung

140 activated B cells and A20 were diminished in peripheral blood mononuclear cells of sepsis patients, w

141 imulation by M. leprae antigens in the PBMC (peripheral blood mononuclear cells) of 69 healthy people

142 , combined delivery of ICOVIR-15K-cBiTE with peripheral blood mononuclear cells or T cells enhanced t

143 Peripheral blood mononuclear cells or whole blood were c

144 dies from serum and multiple cell types from peripheral blood mononuclear cells or whole blood.

145 gnitude (2300 vs 70 spot-forming cells/10(6) peripheral blood mononuclear cells; P = .06) in vaccinee

146 ll subjects remained off ERT with normalized peripheral blood mononuclear cell (PBMC) ADA activity, i

147 ing to profile DENV-3 intrahost diversity in peripheral blood mononuclear cell (PBMC) and plasma samp

148 e homologous infectious molecular clone in a peripheral blood mononuclear cell (PBMC) assay.

149 We have taken the standard peripheral blood mononuclear cell (PBMC) based viral out

150 eaction was inhibited by injecting hBMSC and peripheral blood mononuclear cell (PBMC) co-cultured exo

151 liferation and the secretion of cytokines in Peripheral blood mononuclear cell (PBMC) culture from CM

152 sample with whole blood concentration of the peripheral blood mononuclear cell (PBMC) fraction were e

153 We investigated peripheral blood mononuclear cell (PBMC) microRNA and pr

154 n delaying time to viral rebound or reducing peripheral blood mononuclear cell (PBMC) or lymph node p

155 Suppression of parasite-specific peripheral blood mononuclear cell (PBMC) proliferation w

156 We recently showed proliferative peripheral blood mononuclear cell (PBMC) responses to al

157 ctions, an ex vivo co-culture model of human peripheral blood mononuclear cell (PBMC) responses to Es

158 We investigated 607 peripheral blood mononuclear cell (PBMC) samples from 10

159 ion of cholesterol efflux capacity (CEC) and peripheral blood mononuclear cell (PBMC) transcriptomics

160 SCs deliver miR-9 to the injured pancreas or peripheral blood mononuclear cell (PBMC), which can targ

161 elated with proviral HIV-DNA copy numbers in peripheral blood mononuclear cells (PBMC) (Rho = 0.4011;

162 transcripts were significantly increased in peripheral blood mononuclear cells (PBMC) along with the

163 plore the use of gene expression patterns in peripheral blood mononuclear cells (PBMC) as a first ste

164 al human MCF10A mammary epithelial and human peripheral blood mononuclear cells (PBMC) by MTT assay.

165 dult NOD/Scidgammac(-/-) (NSG) mice received peripheral blood mononuclear cells (PBMC) derived from a

166 ntibodies in ex vivo cultures of naive human peripheral blood mononuclear cells (PBMC) exposed to P.

167 Peripheral blood mononuclear cells (PBMC) from 20 HDM-al

168 Peripheral blood mononuclear cells (PBMC) from 20 HDM-al

169 Peripheral blood mononuclear cells (PBMC) from 52 HDM al

170 ORMDL expression was evaluated in peripheral blood mononuclear cells (PBMC) from 55 subjec

171 Mycobacterial growth in peripheral blood mononuclear cells (PBMC) from both huma

172 As expected, MDSC isolated from peripheral blood mononuclear cells (PBMC) from cancer pa

173 f CCR5 does not prevent ex vivo infection of peripheral blood mononuclear cells (PBMC) from SM or ver

174 Peripheral blood mononuclear cells (PBMC) from these gro

175 trated for (E1)-3s coadministered with human peripheral blood mononuclear cells (PBMC) in NOD/SCID mi

176 VagmVer replicated efficiently in AGM and RM peripheral blood mononuclear cells (PBMC) in the presenc

177 we show that pCREB expression is reduced in peripheral blood mononuclear cells (PBMC) of AD subjects

178 cyte chemoattractant protein MCP-1, which in peripheral blood mononuclear cells (PBMC) stimulated the

179 ed to examine transcriptional differences in peripheral blood mononuclear cells (PBMC), and in purifi

180 und L-45 shows no observable cytotoxicity in peripheral blood mononuclear cells (PBMC), good cell-per

181 l HT-29 carcinoma cells and allogeneic human peripheral blood mononuclear cells (PBMC), or with a pat

182 sed genes (DEGs) within whole blood (WB) and peripheral blood mononuclear cells (PBMC).

183 sented approximately 0.1% of the circulating peripheral blood mononuclear cells (PBMC).

184 city (CEC) and changes in gene expression in peripheral blood mononuclear cells (PBMC).

185 V-1 DNA longitudinally for up to 14 years in peripheral blood mononuclear cells (PBMCs) among 61 peri

186 irus (CMV)-pp65-specific T-cell responses in peripheral blood mononuclear cells (PBMCs) and breast mi

187 Here we found that human peripheral blood mononuclear cells (PBMCs) and cell line

188 Here we report that in human peripheral blood mononuclear cells (PBMCs) and inflamed

189 evious studies, OM-specific proliferation of peripheral blood mononuclear cells (PBMCs) and interfero

190 -related receptor type 4 (CCR5 and CXCR4) on peripheral blood mononuclear cells (PBMCs) and macrophag

191 We used ex vivo stimulations of peripheral blood mononuclear cells (PBMCs) and monocytes

192 The proportion of peripheral blood mononuclear cells (PBMCs) and of CSF wh

193 Peripheral blood mononuclear cells (PBMCs) and plasma we

194 luding plasma HIV RNA and nested PCR on bulk peripheral blood mononuclear cells (PBMCs) and sigmoid b

195 c induction in freshly isolated B cells from peripheral blood mononuclear cells (PBMCs) and that acti

196 L-17-positive T cells were sorted from human peripheral blood mononuclear cells (PBMCs) by intracellu

197 L-17-positive T cells were sorted from human peripheral blood mononuclear cells (PBMCs) by intracellu

198 METHODS AND We prospectively collected peripheral blood mononuclear cells (PBMCs) by leukaphere

199 Interestingly, using peripheral blood mononuclear cells (PBMCs) collected at

200 ene expression profiles using microarrays on peripheral blood mononuclear cells (PBMCs) from 18 early

201 Peripheral blood mononuclear cells (PBMCs) from 20 healt

202 luated the presence of the Warburg effect in peripheral blood mononuclear cells (PBMCs) from 30 premu

203 formance characteristics of the assays using peripheral blood mononuclear cells (PBMCs) from 5 viremi

204 ype 1 (AF DENV-1) together with AF DENV-2 on peripheral blood mononuclear cells (PBMCs) from children

205 Peripheral blood mononuclear cells (PBMCs) from donors p

206 In this study, we screened peripheral blood mononuclear cells (PBMCs) from donors v

207 cell lines, cocultured with freshly isolated peripheral blood mononuclear cells (PBMCs) from healthy

208 elective TLR7 agonist GS-9620 induced HIV in peripheral blood mononuclear cells (PBMCs) from HIV-infe

209 Peripheral blood mononuclear cells (PBMCs) from infectio

210 Further, in peripheral blood mononuclear cells (PBMCs) from patients

211 In addition, upon direct IFNalpha exposure, peripheral blood mononuclear cells (PBMCs) from patients

212 Ex vivo-isolated peripheral blood mononuclear cells (PBMCs) from peanut-a

213 leal biopsies from sites of inflammation and peripheral blood mononuclear cells (PBMCs) from treatmen

214 SCC spheroids were co-cultured in vitro with peripheral blood mononuclear cells (PBMCs) in the presen

215 Here, we analyse ZIKV infectivity of peripheral blood mononuclear cells (PBMCs) in vitro and

216 we were also able to reprogram blood-derived peripheral blood mononuclear cells (PBMCs) into iPSCs.

217 Peripheral blood mononuclear cells (PBMCs) obtained from

218 cance of detecting EBV DNA in the plasma and peripheral blood mononuclear cells (PBMCs) of 2146 patie

219 rallel sequencing to quantitate mutations in peripheral blood mononuclear cells (PBMCs) of 686 women

220 er experiments performed with compound 15 on peripheral blood mononuclear cells (PBMCs) of chronic ly

221 ranscriptional and epigenetic differences in peripheral blood mononuclear cells (PBMCs) of monozygoti

222 8) clones, using a novel strategy of pooling peripheral blood mononuclear cells (PBMCs) of six select

223 rriers had a higher IL-37 gene expression in peripheral blood mononuclear cells (PBMCs) than GG carri

224 lex virus-1 (HSV-1) potently activates human peripheral blood mononuclear cells (PBMCs) to lyse leuke

225 The proliferative response of human peripheral blood mononuclear cells (PBMCs) to S. aureus

226 d DNA methylation at baseline and 3 hours in peripheral blood mononuclear cells (PBMCs) using the Inf

227 Peripheral blood mononuclear cells (PBMCs) were also iso

228 ce marker expression (CD3, CD4 and CXCR3) in peripheral blood mononuclear cells (PBMCs) were assayed.

229 Human peripheral blood mononuclear cells (PBMCs) were isolated

230 Levels of integrated HIV DNA in peripheral blood mononuclear cells (PBMCs) were longitud

231 uid (CSF), plasma, and very large numbers of peripheral blood mononuclear cells (PBMCs) were obtained

232 Human peripheral blood mononuclear cells (PBMCs) were stimulat

233 G) mice intrasplenically injected with human peripheral blood mononuclear cells (PBMCs) which develop

234 -Barr virus-transformed B (EBV) cells, human peripheral blood mononuclear cells (PBMCs), and mouse sp

235 this barrier, we isolated mRNAs from feline peripheral blood mononuclear cells (PBMCs), and used ava

236 , CD31(+) , CD34(+) /VEGFR2(+) and CD62E(+) peripheral blood mononuclear cells (PBMCs), muscle mitoc

237 Bmem cells to CTD1 was also evident in human peripheral blood mononuclear cells (PBMCs), suggesting t

238 elper/memory and cytotoxic T cells (CTLs) in peripheral blood mononuclear cells (PBMCs).

239 Primary outcome was HO-1 upregulation in peripheral blood mononuclear cells (PBMCs).

240 a and IL-18 from mouse macrophages and human peripheral blood mononuclear cells (PBMCs).

241 tructures present on HIV-1 gp120 produced in peripheral blood mononuclear cells (PBMCs).

242 kine secretion, and the recruitment of human peripheral blood mononuclear cells (PBMCs).

243 s applied for the quantitation of HIV RNA in peripheral blood mononuclear cells (PBMCs; n = 72), semi

244 novo infections of various cell types (human peripheral blood mononuclear cells [PBMCs], CD14(+) mono

245 and the results were further validated with peripheral blood mononuclear cells (PBMNCs) isolated fro

246 DNA methylation differences between matched peripheral blood mononuclear cells (PMBCs) and buccal ep

247 CD28(null) cells proliferated in response to peripheral blood mononuclear cells previously exposed to

248 Anti-HER2 Th1 responses were examined using peripheral blood mononuclear cells pulsed with 6 HER2-de

249 ctor 4 and B-cell lymphoma 6 (BCL6) in human peripheral blood mononuclear cells purified from active

250 in vitro, healthy donor peripheral blood mononuclear cells, purified B cells, mo

251 Secondly, we analyzed co-cultures with human peripheral blood mononuclear cells, purified monocytes,

252 e immunological mechanisms in patient serum, peripheral blood mononuclear cells, rejected kidney tiss

253 By contrast, the patient's peripheral blood mononuclear cells responded normally to

254 Inhibiting CDK9 activity in peripheral blood mononuclear cells resulted in the loss

255 hildren (6-36 months old) provided serum and peripheral blood mononuclear cell samples after their pr

256 We investigated 604 peripheral blood mononuclear cell samples from 108 CMV-

257 se-control immunology study; 84 preinfection peripheral blood mononuclear cell samples from individua

258 n-presenting cell responses were assessed in peripheral blood mononuclear cell samples with flow cyto

259 sites using a combination of 262 skin and 48 peripheral blood mononuclear cell samples.

260 d an allogeneic HCT and had archived pre-HCT peripheral blood mononuclear cell samples.

261 Peripheral blood mononuclear cells samples were stained

262 Stimulated patients' fibroblasts and peripheral blood mononuclear cells showed evidence for i

263 e hypotheses, we prospectively collected 177 peripheral blood mononuclear cell specimens from 39 lung

264 , we found higher frequency of pTfh cells in peripheral blood mononuclear cell specimens from the ALV

265 cubation of cfTERRA-containing exosomes with peripheral blood mononuclear cells stimulated transcript

266 and IL-6 by ITF2357 with that of ITF3056 in peripheral blood mononuclear cells stimulated with lipop

267 They also demonstrate unambiguously that peripheral blood mononuclear cell subpopulations display

268 ted an expanded host range in primary rhesus peripheral blood mononuclear cells that included CCR5(+)

269 We profiled 68k peripheral blood mononuclear cells to demonstrate the sy

270 blast cells from heparinised blood and human peripheral blood mononuclear cells to establish the acti

271 Moreover, exposure of naive peripheral blood mononuclear cells to exosomes purified

272 ontributing to an exaggerated recruitment of peripheral blood mononuclear cells to pulmonary iPAH ECs

273 increased arterial inflammation and enhanced peripheral blood mononuclear cells trafficking to the ar

274 athway-based signature derived from grouping peripheral blood mononuclear cell transcriptomes disting

275 erage of 16.5 +/- 9.0% of pretransplantation peripheral blood mononuclear cell Treg cell were donor-r

276 In vitro secretion of these miRNAs by peripheral blood mononuclear cells was also significantl

277 The production of cytokines by peripheral blood mononuclear cells was assayed, as were

278 on-alpha and interferon-lambda production by peripheral-blood mononuclear cells was diminished after

279 During the treatment, peripheral blood mononuclear cells were analyzed for reg

280 Plasma and peripheral blood mononuclear cells were collected at mul

281 eactions, global transcriptional profiles of peripheral blood mononuclear cells were compared between

282 Peripheral blood mononuclear cells were cultured unstimu

283 mean florescent intensity fell when healthy peripheral blood mononuclear cells were cultured with po

284 Pancreatic acini and peripheral blood mononuclear cells were exposed to FAs o

285 Human primary TEC and peripheral blood mononuclear cells were infected with BK

286 Peripheral blood mononuclear cells were isolated and sti

287 C4 fraction of complement, and cryoglobulin; peripheral blood mononuclear cells were isolated for flo

288 Peripheral blood mononuclear cells were isolated from ac

289 To analyze the level of DNA DSBs, peripheral blood mononuclear cells were isolated from bl

290 Peripheral blood mononuclear cells were obtained at week

291 Peripheral blood mononuclear cells were obtained from ch

292 DNA genotyping and mRNA expression levels in peripheral blood mononuclear cells were quantified via m

293 Peripheral blood mononuclear cells were stained with mon

294 Peripheral blood mononuclear cells were stimulated for 1

295 Separately, matched peripheral blood mononuclear cells were stimulated in vi

296 Peripheral blood mononuclear cells were stimulated with

297 -6, IL-10, and IL-12 by monocytes from human peripheral blood mononuclear cells, while its isogenic n

298 pecific immunity was assessed by stimulating peripheral blood mononuclear cells with CMV pp65 or IE-1

299 We observed that pretreatment of human peripheral blood mononuclear cells with HMBA led to a ma

300 Treatment of peripheral blood mononuclear cells with IL-15 induced a